Peter Rahmer, See remarks at Relay Therapeutics, Inc. (RLAY), sold 72,005 shares at $4.42 ($326K) on 2025-01-30, disclosed to the SEC on 2025-01-30.
Open-market sale of $326k RLAY by See remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.63 | 1,673 | $8K | 2.4% |
| 2 | $4.55 | 26,541 | $121K | 37.1% |
| 3 | $4.55 | 26,541 | $121K | 37.1% |
| 4 | $4.42 | 17,250 | $76K | 23.4% |
| Total | $4.52 avg | 72,005 | $326K | 100% |
| Filing → |
| RLAY | SELL | 2026-07-02 | $955K | — | Filing → |
| RLAY | SELL | 2026-04-30 | $11K | — | Filing → |
| RLAY | SELL | 2026-01-29 | $100K | — | Filing → |